Literature DB >> 12456789

Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development.

Sandra L Grimm1, Tiffany N Seagroves, Elena B Kabotyanski, Russell C Hovey, Barbara K Vonderhaar, John P Lydon, Keiko Miyoshi, Lothar Hennighausen, Christopher J Ormandy, Adrian V Lee, Malinda A Stull, Teresa L Wood, Jeffrey M Rosen.   

Abstract

Targeted deletion of the bZIP transcription factor, CCAAT/enhancer binding protein-beta (C/EBPbeta), was shown previously to result in aberrant ductal morphogenesis and decreased lobuloalveolar development, accompanied by an altered pattern of progesterone receptor (PR) expression. Here, similar changes in the level and pattern of prolactin receptor (PrlR) expression were observed while screening for differentially expressed genes in C/EBPbeta(null) mice. PR patterning was also altered in PrlR(null) mice, as well as in mammary tissue transplants from both PrlR(null) and signal transducer and activator of transcription (Stat) 5a/b-deficient mice, with concomitant defects in hormone-induced proliferation. Down-regulation of PR and activation of Stat5 phosphorylation were seen after estrogen and progesterone treatment in both C/EBPbeta(null) and wild-type mice, indicating that these signaling pathways were functional, despite the failure of steroid hormones to induce proliferation. IGF binding protein-5, IGF-II, and insulin receptor substrate-1 all displayed altered patterns and levels of expression in C/EBPbeta(null) mice, suggestive of a change in the IGF signaling axis. In addition, small proline-rich protein (SPRR2A), a marker of epidermal differentiation, and keratin 6 were misexpressed in the mammary epithelium of C/EBPbeta(null) mice. Together, these data suggest that C/EBPbeta is a master regulator of mammary epithelial cell fate and that the correct spatial pattern of PR and PrlR expression is a critical determinant of hormone-regulated cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456789     DOI: 10.1210/me.2002-0239

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  51 in total

1.  Activation of the aryl hydrocarbon receptor during pregnancy in the mouse alters mammary development through direct effects on stromal and epithelial tissues.

Authors:  Betina J Lew; Ravikumar Manickam; B Paige Lawrence
Journal:  Biol Reprod       Date:  2011-01-26       Impact factor: 4.285

Review 2.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 3.  Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function.

Authors:  Sandra Gass; Jessica Harris; Chris Ormandy; Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 4.  Hormone action in the mammary gland.

Authors:  Cathrin Brisken; Bert O'Malley
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-25       Impact factor: 10.005

Review 5.  Alveolar and lactogenic differentiation.

Authors:  Cathrin Brisken; Renuga Devi Rajaram
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

6.  Transcriptional response of the murine mammary gland to acute progesterone exposure.

Authors:  Rodrigo Fernandez-Valdivia; Atish Mukherjee; Chad J Creighton; Adam C Buser; Francesco J DeMayo; Dean P Edwards; John P Lydon
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

Review 7.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

Review 8.  Minireview: hormones and mammary cell fate--what will I become when I grow up?

Authors:  Heather L LaMarca; Jeffrey M Rosen
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

9.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

10.  CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.

Authors:  Heather L LaMarca; Adriana P Visbal; Chad J Creighton; Hao Liu; Yiqun Zhang; Fariba Behbod; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.